An additional LOH event was observed in major histocompatibility complex, class IA (HLA-A) in the subcutaneous PDX and PDOX, but not in the patient tumor (Fig. 1G; Table S1), raising the possibility of the evolution of a tumor cell clone(s) with expression of neoantigens in xenografts. This evidence concerns the gene HLA-A and neoplasm.